RumbleOn Announces First Quarter 2023 Earnings Release and Conference Call Schedule
RumbleOn, Inc. (NASDAQ: RMBL) (the "Company" or "RumbleOn"), the nation's first technology-based omnichannel powersports platform, today announced that it will release its first quarter 2023 operational and financial results before the market opens on Wednesday, May 10, 2023.
The Company has scheduled a conference call and webcast on the same day at 7:30 a.m. Central Time (8:30 a.m. Eastern Time) to discuss its operational and financial results.
What: RumbleOn First Quarter 2023 Earnings Conference Call
When: Wednesday, May 10, 2023, at 7:30 a.m. Central Time (8:30 a.m. Eastern Time)
Conference Call Dial In: 1-877-407-9716 for United States callers, or 1-201-493-6779 for callers outside the United States; Conference ID: 13737567
Webcast: A live and archived webcast of the event will be accessible from the Investor Relations section of the company's website at https://investors.rumbleon.com
About RumbleOn
RumbleOn is the nation's first technology-based omnichannel powersports platform. Headquartered in the Dallas Metroplex, RumbleOn provides the only technology-led omnichannel platform in powersports with a broad footprint of physical locations, full-line manufacturer representation and high-quality used inventory to transform the entire customer experience. Our goal is to integrate the best of both the physical and digital, and make the transition between the two seamless. To learn more please visit us online at https://www.rumbleon.com.
Forward-looking Statements
Our First Quarter 2023 earnings release and conference call may contain forward-looking information that involve risks and uncertainties that may cause actual results to differ materially from those discussed. Additional information about these risks and uncertainties can be found in RumbleOn's periodic and other SEC filings, including our most recently filed Form 10-K. The forward-looking statements in the earnings release and on the conference call, including responses to your questions, are based on current expectations as of the time of release and the call, and RumbleOn assumes no obligation to update or revise them, whether as a result of new developments or otherwise, except as required by law.
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week.
"With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...